Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 140

    1.

    Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease.

    Mooser V, Helbecque N, Miklossy J, Marcovina SM, Nicod P, Amouyel P.

    Ann Intern Med. 2000 Apr 4;132(7):533-7.PMID: 10744589 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.

    Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H.

    Ann Intern Med. 2002 Aug 6;137(3):149-55.PMID: 12160362 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.

    Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM.

    Arch Neurol. 2000 Nov;57(11):1579-83.PMID: 11074789 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk]

    Hernández-Charro B, Moreno S, Valiente A, Manubens JM, Villar MD, Ramos-Arroyo MA.

    Med Clin (Barc). 2004 Sep 4;123(7):251-4. Spanish. PMID: 15482730 [PubMed - indexed for MEDLINE]Related articles

    5.

    APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

    Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO.

    BMC Neurol. 2008 Apr 16;8:9.PMID: 18416843 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.

    Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H, Ueki A, Kitamura S, Namekata K, Miki T, Ohta S.

    Biochem Biophys Res Commun. 2000 Jun 24;273(1):192-6.PMID: 10873585 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.

    Mattila KM, Rinne JO, Röyttä M, Laippala P, Pietilä T, Kalimo H, Koivula T, Frey H, Lehtimäki T.

    J Med Genet. 2000 Oct;37(10):766-70.PMID: 11015454 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.

    Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, D'Angelo A, Montagna L, Bruni AC, Geroldi D.

    Neurosci Lett. 2004 Feb 26;357(1):45-8.PMID: 15036610 [PubMed - indexed for MEDLINE]Related articles

    9.

    Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.

    Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C.

    Dement Geriatr Cogn Disord. 2004;18(2):125-31. Epub 2004 Jun 18.PMID: 15211066 [PubMed - indexed for MEDLINE]Related articles

    10.

    Apolipoprotein E genetic variation and Alzheimer's disease. a meta-analysis.

    Rubinsztein DC, Easton DF.

    Dement Geriatr Cogn Disord. 1999 May-Jun;10(3):199-209. Erratum in: Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):238. PMID: 10325447 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele.

    Bernardini S, Bellincampi L, Ballerini S, Federici G, Iori R, Trequattrini A, Ciappi F, Baldinetti F, Bossù P, Caltagirone C, Spalletta G.

    Clin Chem. 2005 Jun;51(6):944-51. Epub 2005 Apr 1.PMID: 15805147 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

    Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H.

    Neurology. 2006 Jan 24;66(2):223-7.PMID: 16434658 [PubMed - indexed for MEDLINE]Related articles

    13.

    Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.

    van Vliet P, Westendorp RG, Eikelenboom P, Comijs HC, Frölich M, Bakker E, van der Flier W, van Exel E.

    Neurology. 2009 Sep 1;73(9):681-7.PMID: 19720974 [PubMed - indexed for MEDLINE]Related articles

    14.

    Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.

    Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, Adamson JL, Griffith P, Willis FB, Williams M, Hipps Y, Haines JL, Cupples LA, Farrer LA.

    Arch Neurol. 2002 Apr;59(4):594-600.PMID: 11939894 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.

    Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J.

    Neurology. 2004 Jun 8;62(11):1977-83.PMID: 15184600 [PubMed - indexed for MEDLINE]Related articles

    16.

    Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.

    Olarte L, Schupf N, Lee JH, Tang MX, Santana V, Williamson J, Maramreddy P, Tycko B, Mayeux R.

    Arch Neurol. 2006 Nov;63(11):1586-90.PMID: 17101827 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.

    Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, Van Deerlin V, Yuan W, Bird TD.

    Arch Neurol. 2006 Sep;63(9):1307-11.PMID: 16966510 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.

    Cui T, Zhou X, Jin W, Zheng F, Cao X.

    Chin Med J (Engl). 2000 Apr;113(4):340-4.PMID: 11775232 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

    Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

    Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.PMID: 15664112 [PubMed - indexed for MEDLINE]Related articles

    20.

    Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.

    Roussos L, Ekström U, Ehle PN, Oqvist B, Floren CH.

    Scand J Urol Nephrol. 2004;38(6):504-10.PMID: 15841787 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data